Intraperitoneal free cancer cells in gastric adenocarcinoma are associated with a poor outcome. However, the true prognostic value of intraperitoneal free cancer cells is still unclear, leading to a lack of consensus in the management of gastric cancer. The aim of the present study is to perform a systematic review and meta-analysis to analyze intraperitoneal free cancer cells-positive patients...

The AGO Kommission Ovar already published a statement in 2013, warning about the uncritical use of hyperthermic intraperitoneal chemotherapy (HIPEC) outside controlled studies. This statement has now been updated after the most recent literature was reviewed by AGO Kommission Ovar, the AGO Study Group, NOGGO, AGO Austria and AGO Switzerland. The authors conclude that HIPEC remains experimental....

Soft spelling mistakes are a class of that is widespread among native Arabic speakers and foreign learners alike. Some these typographical in nature. They occur due to orthographic variations some letters the complex rules dictate their correct usage. Many people forgo rules, given identical phonetic sounds, they often confuse such letters. In this paper, we investigate how use machine learning...

In January 2006, a clinical announcement made by the National Cancer Institute suggested that intraperitoneal chemotherapy become standard care for patients with newly diagnosed stage III, optimally debulked epithelial ovarian cancer. Intraperitoneal chemotherapy is new to many healthcare providers (i.e., physicians, nurses, and pharmacists). This article will discuss how to implement intraperi...

BACKGROUND Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has become a common treatment approach for disseminated appendiceal neoplasms. Systemic absorption of intraperitoneal chemotherapeutics may lead to drug-induced toxicity, most commonly neutropenia. Mitomycin C has been the most commonly used chemotherapeutic in HIPEC for the past several decades...

The role of hyperthermic intraperitoneal chemoperfusion (HIPEC) in the treatment of Pseudomyxoma peritonei is debated by clinicians. We report the case of a patient who had multiple episodes of short-interval disease recurrence following debulking surgery, and only achieved long-term remission with the addition of HIPEC. A review of the relevant literature is presented.